These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1974070)

  • 1. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with alpidem in normal volunteers and anxious patients.
    Morton S; Lader M
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clorazepate, diazepam, lorazepam, and placebo on human memory.
    Healey M; Pickens R; Meisch R; McKenna T
    J Clin Psychiatry; 1983 Dec; 44(12):436-9. PubMed ID: 6140261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of hydroxyzine on attention and memory in elderly subjects].
    De Brabander A; Deberdt W
    Acta Psychiatr Belg; 1992; 92(6):370-82. PubMed ID: 1345410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S; Lader M
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpidem and psychological performance in elderly subjects.
    Hindmarch I
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():124-8. PubMed ID: 1974072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.
    Brignell CM; Rosenthal J; Curran HV
    J Psychopharmacol; 2007 Sep; 21(7):673-83. PubMed ID: 17606475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers.
    Patat A; Perault MC; Vandel B; Danjou P; Brohier S; Zieleniuk I; Rosenzweig P
    J Psychopharmacol; 1995 Jan; 9(2):91-101. PubMed ID: 22298734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A
    Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterograde amnesia with oral lorazepam.
    Mac DS; Kumar R; Goodwin DW
    J Clin Psychiatry; 1985 Apr; 46(4):137-8. PubMed ID: 3980452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
    Lister RG; File SE
    J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
    Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
    Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.